{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:07:41Z","timestamp":1769242061496,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T00:00:00Z","timestamp":1434153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00063-015-0043-x","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T12:03:20Z","timestamp":1434110600000},"page":"447-452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatokardiale Wechselwirkungen","Hepatocardiac disorders"],"prefix":"10.1007","volume":"111","author":[{"given":"T.","family":"Horvatits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Drolz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Roedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,13]]},"reference":[{"key":"43_CR1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2009.12.075","volume":"56","author":"EM Zardi","year":"2010","unstructured":"Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW et al (2010) Cirrhotic cardiomyopathy. J Am Coll Cardiol 56:539\u2013549","journal-title":"J Am Coll Cardiol"},{"key":"43_CR2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.2006.112177","volume":"57","author":"S Moller","year":"2008","unstructured":"Moller S, Henriksen JH (2008) Cardiovascular complications of cirrhosis. Gut 57:268\u2013278","journal-title":"Gut"},{"key":"43_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","volume":"11","author":"S Wiese","year":"2014","unstructured":"Wiese S, Hove JD, Bendtsen F, Moller S (2014) Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 11:177\u2013186","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"43_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2012.08.027","volume":"58","author":"A Nazar","year":"2013","unstructured":"Nazar A, Guevara M, Sitges M, Terra C, Sola E, Guigou C et al (2013) LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. J Hepatol 58:51\u201357","journal-title":"J Hepatol"},{"key":"43_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1665-2681(19)31544-3","volume":"10","author":"NX Ortiz-Olvera","year":"2011","unstructured":"Ortiz-Olvera NX, Castellanos-Pallares G, Gomez-Jimenez LM, Cabrera-Munoz ML, Mendez-Navarro J, Moran-Villota S et al (2011) Anatomical cardiac alterations in liver cirrhosis: an autopsy study. Ann Hepatol 10:321\u2013326","journal-title":"Ann Hepatol"},{"key":"43_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heart.87.1.9","volume":"87","author":"S Moller","year":"2002","unstructured":"Moller S, Henriksen HJ (2002) Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 87:9\u201315","journal-title":"Heart"},{"key":"43_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2010.02.023","volume":"53","author":"S Moller","year":"2010","unstructured":"Moller S Henriksen HJ (2010) Cirrhotic cardiomyopathy. J Hepatol 53:179\u2013190","journal-title":"J Hepatol"},{"key":"43_CR8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2001.28653","volume":"121","author":"CA Ward","year":"2001","unstructured":"Ward CA, Liu H, Lee SS (2001) Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy. Gastroenterology 121:1209\u20131218","journal-title":"Gastroenterology"},{"key":"43_CR9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","volume":"57","author":"A Bortoluzzi","year":"2013","unstructured":"Bortoluzzi A, Ceolotto G, Gola E, Sticca A, Bova S, Morando F et al (2013) Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms. Hepatology 57:266\u2013276","journal-title":"Hepatology"},{"key":"43_CR10","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.26509","volume":"58","author":"L Ruiz-del-Arbol","year":"2013","unstructured":"Ruiz-del-Arbol L, Achecar L, Serradilla R, Rodriguez-Gandia MA, Rivero M, Garrido E et al (2013) Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine. Hepatology 58:1732\u20131741","journal-title":"Hepatology"},{"key":"43_CR11","first-page":"67","volume":"8","author":"M Farr","year":"2014","unstructured":"Farr M, Schulze PC (2014) Recent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo imaging, cardiac biomarkers, and advanced heart failure therapies. Clin Med Insights Cardiol 8:67\u201374","journal-title":"Clin Med Insights Cardiol"},{"key":"43_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2003.10.026","volume":"40","author":"JH Henriksen","year":"2004","unstructured":"Henriksen JH, Bendtsen F, Hansen EF, Moller S (2004) Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. J Hepatol 40:239\u2013246","journal-title":"J Hepatol"},{"key":"43_CR13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","volume":"52","author":"T Serste","year":"2010","unstructured":"Serste T, Melot C, Francoz C, Durand F, Rautou PE, Valla D et al (2010) Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 52:1017\u20131022","journal-title":"Hepatology"},{"key":"43_CR14","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","volume":"146","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Kruzik M et al (2014) Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology 146:1680\u20131690 e1681","journal-title":"Gastroenterology"},{"key":"43_CR15","doi-asserted-by":"crossref","first-page":"D","DOI":"10.1016\/j.jacc.2013.10.029","volume":"62","author":"G Simonneau","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:D34\u2013D41","journal-title":"J Am Coll Cardiol"},{"key":"43_CR16","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR et al (2009) ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119:2250\u20132294","journal-title":"Circulation"},{"key":"43_CR17","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Galie","year":"2009","unstructured":"Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30:2493\u20132537","journal-title":"Eur Heart J"},{"key":"43_CR18","doi-asserted-by":"crossref","first-page":"D","DOI":"10.1016\/j.jacc.2013.10.032","volume":"62","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M et al (2013) Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62:D42\u2013D50","journal-title":"J Am Coll Cardiol"},{"key":"43_CR19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00508-013-0337-z","volume":"125","author":"M Peck-Radosavljevic","year":"2013","unstructured":"Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V et al (2013) Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr 125:200\u2013219","journal-title":"Wien Klin Wochenschr"},{"key":"43_CR20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","volume":"24","author":"R Rodriguez-Roisin","year":"2004","unstructured":"Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB (2004) Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 24:861\u2013880","journal-title":"Eur Respir J"},{"key":"43_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/17512433.2014.857598","volume":"7","author":"T Horvatits","year":"2014","unstructured":"Horvatits T, Fuhrmann V (2014) Therapeutic options in pulmonary hepatic vascular diseases. Expert Rev Clin Pharmacol 7:31\u201342","journal-title":"Expert Rev Clin Pharmacol"},{"key":"43_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1164\/rccm.201209-1583CI","volume":"187","author":"JS Fritz","year":"2013","unstructured":"Fritz JS, Fallon MB, Kawut SM (2013) Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med 187:133\u2013143","journal-title":"Am J Respir Crit Care Med"},{"key":"43_CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00063-013-0319-y","volume":"109","author":"T Horvatits","year":"2014","unstructured":"Horvatits T, Drolz A, Rutter K, Kluge S, Fuhrmann V (2014) [Pulmonary complications in liver diseases]. Med Klin Intensivmed Notfmed 109:235\u2013239","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"43_CR24","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","volume":"8","author":"KL Swanson","year":"2008","unstructured":"Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ (2008) Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant 8:2445\u20132453","journal-title":"Am J Transplant"},{"key":"43_CR25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","volume":"178","author":"Le Pavec J","year":"2008","unstructured":"Le Pavec J, Souza R, Herve P, Lebrec D, Savale L, Tcherakian C et al (2008) Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med 178:637\u2013643","journal-title":"Am J Respir Crit Care Med"},{"key":"43_CR26","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/ajt.12783","volume":"14","author":"DS Goldberg","year":"2014","unstructured":"Goldberg DS, Batra S, Sahay S, Kawut SM, Fallon MB (2014) MELD exceptions for portopulmonary hypertension: current policy and future implementation. Am J Transplant 14:2081\u20132087","journal-title":"Am J Transplant"},{"key":"43_CR27","doi-asserted-by":"crossref","first-page":"528783","DOI":"10.1155\/2014\/528783","volume":"2014","author":"M Faisal","year":"2014","unstructured":"Faisal M, Siddiqi F, Alkaddour A, Bajwa AA, Shujaat A (2014) Effect of PAH specific therapy on pulmonary hemodynamics and six-minute walk distance in portopulmonary hypertension: a systematic review and meta-analysis. Pulm Med 2014:528783","journal-title":"Pulm Med"},{"key":"43_CR28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/hep.510290202","volume":"29","author":"J Henrion","year":"1999","unstructured":"Henrion J, Minette P, Colin L, Schapira M, Delannoy A, Heller FR (1999) Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology 29:427\u2013433","journal-title":"Hepatology"},{"key":"43_CR29","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00134-009-1508-2","volume":"35","author":"V Fuhrmann","year":"2009","unstructured":"Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A et al (2009) Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 35:1397\u20131405","journal-title":"Intensive Care Med"},{"key":"43_CR30","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s00134-011-2248-7","volume":"37","author":"V Fuhrmann","year":"2011","unstructured":"Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A et al (2011) Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37:1302\u20131310","journal-title":"Intensive Care Med"},{"key":"43_CR31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00063-013-0320-5","volume":"109","author":"A Drolz","year":"2014","unstructured":"Drolz A, Horvatits T, Roedl K, Fuhrmann V (2014) [Shock liver and cholestatic liver in critically ill patients]. Med Klin Intensivmed Notfmed 109:228\u2013234","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"43_CR32","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/hep.25896","volume":"56","author":"B Jager","year":"2012","unstructured":"Jager B, Drolz A, Michl B, Schellongowski P, Bojic A, Nikfardjam M et al (2012) Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology 56:2297\u20132304","journal-title":"Hepatology"},{"key":"43_CR33","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00134-013-2926-8","volume":"39","author":"A Drolz","year":"2013","unstructured":"Drolz A, Jager B, Wewalka M, Saxa R, Horvatits T, Roedl K et al (2013) Clinical impact of arterial ammonia levels in ICU patients with different liver diseases. Intensive Care Med 39:1227\u20131237","journal-title":"Intensive Care Med"},{"key":"43_CR34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.gastro.2006.04.014","volume":"131","author":"V Fuhrmann","year":"2006","unstructured":"Fuhrmann V, Madl C, Mueller C, Holzinger U, Kitzberger R, Funk GC et al (2006) Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 131:69\u201375","journal-title":"Gastroenterology"},{"key":"43_CR35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MCC.0b013e32835ec9e6","volume":"19","author":"T Horvatits","year":"2013","unstructured":"Horvatits T, Trauner M, Fuhrmann V (2013) Hypoxic liver injury and cholestasis in critically ill patients. Curr Opin Crit Care 19:128\u2013132","journal-title":"Curr Opin Crit Care"},{"key":"43_CR36","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2014.01.019","volume":"60","author":"A Drolz","year":"2014","unstructured":"Drolz A, Horvatits T, Michl B, Roedl K, Schellongowski P, Holzinger U et al (2014) Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients. J Hepatol 60:1187\u20131193","journal-title":"J Hepatol"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-015-0043-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-015-0043-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-015-0043-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T20:19:29Z","timestamp":1566850769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-015-0043-x"}},"subtitle":["Interaktionen zweier Organsysteme","Interactions between two organ systems"],"short-title":[],"issued":{"date-parts":[[2015,6,13]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1007\/s00063-015-0043-x","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,13]]}}}